ARTICLE
|
doi:10.20944/preprints202111.0257.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
metastatic melanoma; targeted therapy; immune checkpoint inhibitor therapy; survival; statutory health insurance data
Online: 15 November 2021 (11:50:07 CET)